NAGOYA (Kyodo) -- Miyabi Kuroiwa, from Nagoya, central Japan, was 26 when she was diagnosed with stage-4 breast cancer.

a pediatric doctor at Nagoya City University Hospital. Finally, to examine the role of birth-induced upregulation of Glul in RG, they generated Glul-knockdown and -overexpression lentiviruses and ...

A new study found that stimulating CB2, a receptor involved in immune cell function, improved cognitive performance in Alzheimer's disease (AD) mouse models. Researchers showed that activating CB2 ...

Restore Vision Inc., a clinical-stage biotechnology company advancing gene therapies for retinal disorders, today announced that the first patient in its Phase I/II clinical trial with RV-001 has been ...

Miyabi Kuroiwa, from Nagoya, was 26 when she was diagnosed with stage-4 breast cancer. In October 2022, she was taking a bath when she noticed a lump in her left breast. After a doctor's exam revealed ...

Yoshimasa Nagao, deputy director at Nagoya University Hospital, who heads the medical accident investigation committee, reported the results of the investigation at a news conference on Sept.

ASHRAE Hall of Fame Raymond C. Thornton, Fellow Life Member ASHRAE (1923-2018) and William Firth Wells (1887-1963) were ...

In August 2024, a PhD student from the National University of Singapore (NUS) arrived in Nagoya for an internship at Prodrone, as part of a partnership between NUS and Nagoya University.